SCHEMBL3971825

SCHEMBL3971825

CCc1cc(-n2nnc(O)c2-c2c(C(C)C)[nH]c3ccccc23)c(O)cc1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 8/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 2/20 0.35
JUN P05412 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
NPEPPS P55786 1/20 0.34
TBXAS1 P24557 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
DAO P14920 1/20 0.33
DDO Q99489 1/20 0.33
KMT2A Q03164 1/20 0.32
PAX8 Q06710 1/20 0.31
KLK6 Q92876 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1148460 0.75 ALDH1A1 (0.42) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL1148731 0.74 CA12 (0.40) HSP90AA1ALDH1A1KDM4ELMNAMAPT
SCHEMBL3974314 0.73 DAO (0.34) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL3973742 0.72 DAO (0.34) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL1881956 0.69 NPEPPS (0.37) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL3972901 0.68 HSP90AA1 (0.34) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL1148577 0.68 ALDH1A1 (0.48) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL1148534 0.68 DHODH (0.41) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL3974853 0.67 ALDH1A1 (0.35) HSP90AA1ALDH1A1KDM4ELMNATSHR
SCHEMBL1148697 0.67 ALDH1A1 (0.41) HSP90AA1ALDH1A1KDM4ELMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054059-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corporation (US) 2009-05-06 EP claimed
WO-2008021364-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2008-02-21 WO claimed
EP-1817295-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corporation (US) 2007-08-15 EP claimed
WO-2006055760-A9 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP (US) 2006-09-21 WO claimed
WO-2006055760-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2006-05-26 WO claimed
WO-2008112199-A1 METHOD FOR INHIBITING TOPOISOMERASE II SYNTA PHARMACEUTICALS CORP. (US) 2008-09-18 WO disclosed
WO-2007139952-A2 METHOD FOR THE PREPARATION OF TRIAZOLE COMPOUNDS WITH HSP90 MODULATING ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2007-12-06 WO disclosed